As­traZeneca sells two COPD drugs to a fa­mil­iar part­ner as Pas­cal So­ri­ot's on­col­o­gy push march­es on

As CEO Pas­cal So­ri­ot con­tin­ues his long-run­ning piv­ot to­ward on­col­o­gy, As­traZeneca is of­fload­ing an­oth­er pair of res­pi­ra­to­ry drugs.

The drug­mak­er is sell­ing off two med­i­cines …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER